Achieve Life Sciences, Inc. (ACHV) vs Geron Corporation (GERN)

Achieve Life Sciences, Inc. and Geron Corporation are both Biotechnology companies. Achieve Life Sciences, Inc. and Geron Corporation are of similar size ($815.9M and $814.0M). Geron Corporation grew revenue faster over the last twelve months: 24.4% against −5.58%. Achieve Life Sciences, Inc. has the higher net margin (0.00% vs −33.1%) and the higher return on invested capital (0.00% vs −89.9%). Across the 17 metrics below, Geron Corporation leads on 10 and Achieve Life Sciences, Inc. on 7.

Valuation

Metric ACHV GERN Biotechnology median
P/E n/m n/m 7.88
P/S 44.44 4.13 11.47
P/B n/m 3.87 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 33.63 3.59 10.73
Earnings yield (20.61%) (8.37%) (28.84%)
Free cash flow yield (6.69%) (13.58%) (23.03%)

Profitability

Metric ACHV GERN Biotechnology median
Gross margin 0.00% 93.51% 65.16%
Operating margin 0.00% (25.31%) 0.00%
Net margin 0.00% (33.05%) 0.00%
Free cash flow margin 0.00% (56.10%) 0.00%
Return on equity (844.99%) (28.28%) (57.72%)
Return on assets (91.46%) (12.59%) (49.22%)
Return on invested capital 0.00% (89.85%) 0.00%

Growth

Metric ACHV GERN Biotechnology median
Revenue growth (TTM) (5.58%) 24.39% 5.64%
EPS growth (last fiscal year) (0.81%) 51.85% —
Revenue growth, 5-year CAGR (17.95%) 273.49% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACHV GERN Biotechnology median
Debt to equity (1.11) 0.55 0.00
Current ratio 0.95 6.92 4.73
Net debt to EBITDA 0.36 3.28 0.96

Dividend

Metric ACHV GERN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACHV GERN Biotechnology median
Market cap 813.96m 815.94m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack